| 1/3 | US=69 / Câncer Davies M, Patel S, Kim KB. Targeted therapy in melanoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 183-211. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM PACIENTES COM MELANOMA; MELANOMA; TRANSDUCAO DE SINAL; QUINASE DO RECEPTOR; B-RAF; N-RAS; PTEN; MAP QUINASE; NFKB; ANTIOGENESIS; IMMUNOTARGETING |
| 2/3 | US=84 / Biol/Mol Liu F. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulation of smad activity by phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 105-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD; FOSFORILACAO; FOSFATASE; QUINASE DO RECEPTOR; MAP QUINASE; CDK; CANCER |
| 3/3 | US=68 / Biol/Mol Dent P, Hylemon PB, Grant S, Fisher PB. Approaches for monitoring signal transduction changes in normal and cancer cells. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 259-76. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0. TRANSDUCAO DE SINAL; MONITORAMENTO EM CELULAS NORMAIS; MONITORAMENTO EM CELULAS CANCEROSAS; QUINASE; FOSFORILACAO; FOSFORO ESPECIFICO; IMUNOPRECIPITACAO; ERK1/2; MAP QUINASE; JNK1/2; P38; AKT; RAF-1; B-RAF; CDK |